# Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity

> **NCT07135141** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 256 (estimated)

## Conditions studied

- Severe Obesity

## Interventions

- **DRUG:** Sleeve gastrectomy plus early mazdutide initiation
- **DRUG:** Sleeve gastrectomy followed with early mazdutide placebo initation

## Key facts

- **NCT ID:** NCT07135141
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2027-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 256 (ESTIMATED)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135141, "Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07135141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*